BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30184436)

  • 1. Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.
    Morgado I; Panahi A; Burwash AG; Das M; Straub JE; Gursky O
    Biochemistry; 2018 Oct; 57(39):5738-5747. PubMed ID: 30184436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
    Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
    FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
    Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
    J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
    Gursky O; Mei X; Atkinson D
    Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
    Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
    J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.
    Wilson CJ; Das M; Jayaraman S; Gursky O; Engen JR
    Biochemistry; 2018 Jul; 57(30):4583-4596. PubMed ID: 30004693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Apolipoprotein A-1 Amyloidosis With Glu34Lys Mutation Treated by Liver Transplantation: A Case Report.
    Sagawa T; Kogiso T; Ito T; Yasuda H; Katoh N; Yoshinaga T; Yazaki M; Kato T; Omori A; Kotera Y; Egawa H; Yamamoto M; Tokushige K
    Transplant Proc; 2021 May; 53(4):1327-1332. PubMed ID: 33573822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.
    Ramella NA; Schinella GR; Ferreira ST; Prieto ED; Vela ME; Ríos JL; Tricerri MA; Rimoldi OJ
    PLoS One; 2012; 7(8):e43755. PubMed ID: 22952757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants.
    Del Giudice R; Arciello A; Itri F; Merlino A; Monti M; Buonanno M; Penco A; Canetti D; Petruk G; Monti SM; Relini A; Pucci P; Piccoli R; Monti DM
    Biochim Biophys Acta; 2016 Feb; 1860(2):434-44. PubMed ID: 26515634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I induced amyloidosis.
    Genschel J; Haas R; Pröpsting MJ; Schmidt HH
    FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
    Obici L; Bellotti V; Mangione P; Stoppini M; Arbustini E; Verga L; Zorzoli I; Anesi E; Zanotti G; Campana C; Viganò M; Merlini G
    Am J Pathol; 1999 Sep; 155(3):695-702. PubMed ID: 10487826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
    Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
    Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
    Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I.
    Mikawa S; Mizuguchi C; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Sakashita N; Otaka A; Akaji K; Saito H
    FEBS Lett; 2016 Oct; 590(20):3492-3500. PubMed ID: 27654470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.
    Adachi E; Kosaka A; Tsuji K; Mizuguchi C; Kawashima H; Shigenaga A; Nagao K; Akaji K; Otaka A; Saito H
    FEBS Lett; 2014 Jan; 588(3):389-94. PubMed ID: 24316228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of a natural apolipoprotein A-I variant (L60R) associated with amyloidosis.
    Gaddi GM; Gisonno RA; Rosú SA; Curto LM; Prieto ED; Schinella GR; Finarelli GS; Cortez MF; Bauzá L; Elías EE; Ramella NA; Tricerri MA
    Arch Biochem Biophys; 2020 May; 685():108347. PubMed ID: 32194045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
    Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation.
    Andeen NK; Lam DY; de Boer IH; Nicosia RF
    J Am Soc Nephrol; 2014 Dec; 25(12):2703-5. PubMed ID: 24925720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.